|
uricosuric drug
|
CHEBI_35841 |
|
|
gout suppressant
|
CHEBI_35845 |
|
|
antirheumatic drug
|
CHEBI_35842 |
|
|
secondary hypertrophic osteoarthropathy
|
DOID_10393 |
|
|
pneumonic plague
|
DOID_10398 |
|
|
crystallisation adjutant
|
CHEBI_63064 |
|
|
acute megakaryocytic leukemia
|
DOID_8761 |
|
|
acute myeloid leukemia
|
DOID_9119 |
|
|
phenacetin
|
CHEBI_8050 |
|
|
phase-transfer catalyst
|
CHEBI_63060 |
|
|
catalyst
|
CHEBI_35223 |
|
|
EC 2.5.1.9 (riboflavin synthase) inhibitor
|
CHEBI_60901 |
|
|
peripheral nervous system benign neoplasm
|
DOID_0080320 |
|
|
B-Raf inhibitor
|
CHEBI_75047 |
|
|
estradiol
|
CHEBI_23965 |
|
|
T-cell proliferation inhibitor
|
CHEBI_63173 |
|
|
peptidomimetic
|
CHEBI_63175 |
|
|
Nijmegen breakage syndrome
|
DOID_7400 |
|
|
smallpox
|
DOID_8736 |
|
|
EC 5.3.1.* (intramolecular oxidoreductase interconverting aldoses and ketoses) inhibitor
|
CHEBI_90689 |
|
